• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Decreased concentration of xanthine dehydrogenase (EC 1.1.1.204) in rat hepatomas.

作者信息

Ikegami T, Natsumeda Y, Weber G

出版信息

Cancer Res. 1986 Aug;46(8):3838-41.

PMID:3460692
Abstract

Xanthine dehydrogenase (EC 1.1.1.204), the rate-limiting enzyme of purine degradation, was purified 642-fold to homogeneity from liver of male Wistar rats. Antibody was generated to the purified enzyme in white rabbits and was partially purified. For the immunotitration a radioassay of high sensitivity was developed to determine low enzyme activities. Titration curves with the antibody showed that the xanthine dehydrogenase enzyme protein amounts in slowly growing hepatoma 20 and rapidly growing hepatoma 3924A were 34 and 4% of those of normal liver, which was in good agreement with the decrease in the activity of the enzyme to 33 and 2%, respectively. The contents of flavin adenine dinucleotide, the essential cofactor of the enzyme, in the immunoprecipitates in hepatomas 20 and 3924A were 27 and 4% of that of the normal liver. This is the first report to provide immunological evidence that a decreased enzyme activity in rat hepatomas, that of xanthine dehydrogenase, was due to a decrease in the enzyme protein amount. The markedly decreased xanthine dehydrogenase activity and amount have far-reaching biochemical and pharmacological implications for the tumors.

摘要

相似文献

1
Decreased concentration of xanthine dehydrogenase (EC 1.1.1.204) in rat hepatomas.
Cancer Res. 1986 Aug;46(8):3838-41.
2
Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of xanthine oxidase (EC 1.2.3.2).不同生长速率肝癌中嘌呤代谢的失衡,以黄嘌呤氧化酶(EC 1.2.3.2)的表现形式呈现。
Cancer Res. 1976 Dec;36(12):4639-46.
3
Increased carbamoyl-phosphate synthetase II concentration in rat hepatomas: immunological evidence.大鼠肝癌中氨甲酰磷酸合成酶II浓度升高:免疫学证据。
Cancer Res. 1985 Sep;45(9):4412-5.
4
1-Phosphatidylinositol 4-phosphate 5-kinase (EC 2.7.1.68): a proliferation- and malignancy-linked signal transduction enzyme.1-磷脂酰肌醇4-磷酸5-激酶(EC 2.7.1.68):一种与增殖和恶性肿瘤相关的信号转导酶。
Cancer Res. 1994 Nov 1;54(21):5574-8.
5
Phospholipase C (EC 3.1.4.11): a malignancy linked signal transduction enzyme.磷脂酶C(EC 3.1.4.11):一种与恶性肿瘤相关的信号转导酶。
Anticancer Res. 1998 May-Jun;18(3A):1399-404.
6
Increased 5-phospho-alpha-D-ribose-1-diphosphate synthetase (ribosephosphate pyrophosphokinase, EC 2.7.6.1) activity in rat hepatomas.大鼠肝癌中5-磷酸-α-D-核糖-1-二磷酸合成酶(磷酸核糖焦磷酸激酶,EC 2.7.6.1)活性增加。
Cancer Res. 1984 Nov;44(11):5004-9.
7
1-Phosphatidylinositol 4-kinase: an enzyme linked with proliferation and malignancy.1-磷脂酰肌醇4-激酶:一种与增殖和恶性肿瘤相关的酶。
Cancer Res. 1994 May 15;54(10):2611-4.
8
Proliferation-linked increase in phosphoribosylformylglycinamidine synthetase activity (EC 6.3.5.3).与增殖相关的磷酸核糖甲酰甘氨脒合成酶活性(EC 6.3.5.3)增加。
Cancer Res. 1984 Jun;44(6):2430-4.
9
Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) Activities in normal, neoplastic, differentiating, and regenerating liver.转醛醇酶(EC 2.2.1.2)和转酮醇酶(EC 2.2.1.1)在正常、肿瘤、分化及再生肝脏中的活性表现
Cancer Res. 1976 Sep;36(9 pt.1):3189-97.
10
Increased uridine kinase (ATP: uridine 5'-phosphotransferase; EC 2.7.1.48) activity in human and rat tumors.人类和大鼠肿瘤中尿苷激酶(ATP:尿苷5'-磷酸转移酶;EC 2.7.1.48)活性增加。
Cancer Biochem Biophys. 1998 Jun;16(1-2):1-15.

引用本文的文献

1
Exploring the causal association between uric acid and lung cancer in east Asian and European populations: a mendelian randomization study.探讨尿酸与东亚和欧洲人群肺癌之间的因果关联:一项孟德尔随机化研究。
BMC Cancer. 2024 Jul 5;24(1):801. doi: 10.1186/s12885-024-12576-0.
2
Mechanistic insights into the treatment of iron-deficiency anemia and arthritis in humans with dietary molybdenum.膳食钼治疗人类缺铁性贫血和关节炎的作用机制研究。
Eur J Clin Nutr. 2021 Aug;75(8):1170-1175. doi: 10.1038/s41430-020-00845-7. Epub 2021 Jan 29.
3
Xanthine oxidoreductase in cancer: more than a differentiation marker.
癌症中的黄嘌呤氧化还原酶:不仅仅是一种分化标志物。
Cancer Med. 2016 Mar;5(3):546-57. doi: 10.1002/cam4.601. Epub 2015 Dec 21.
4
Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive Oncological Researches Group.一线化疗的非小细胞肺癌患者基线血清尿酸水平的预后意义:土耳其描述性肿瘤学研究组的一项研究
Med Oncol. 2014 Oct;31(10):217. doi: 10.1007/s12032-014-0217-z. Epub 2014 Sep 13.
5
Contribution of uric acid to cancer risk, recurrence, and mortality.尿酸对癌症风险、复发和死亡率的影响。
Clin Transl Med. 2012 Aug 15;1(1):16. doi: 10.1186/2001-1326-1-16.
6
Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer.黄嘌呤氧化还原酶降低是早期胃癌预后不良的一个预测指标。
J Clin Pathol. 2006 Sep;59(9):965-71. doi: 10.1136/jcp.2005.032524.
7
Conversion of xanthine dehydrogenase to xanthine oxidase as a possible marker for hypoxia in tumours and normal tissues.黄嘌呤脱氢酶向黄嘌呤氧化酶的转化作为肿瘤和正常组织缺氧的一种可能标志物。
Br J Cancer. 1989 Aug;60(2):193-7. doi: 10.1038/bjc.1989.249.